Additionally, through mapping SEs in Acute Myeloid Leukemia (AML), a subtype of AML cells with SE-driven RARα was identified to be sensitive to RARα agonist SY-1425 [10]. This evidence concerns the gene RARA and acute myeloid leukemia.